Faculty of Medicine

Alzheimer’s: State-funded research into a target molecule

A potentially groundbreaking discovery for Alzheimer’s sufferers has been given fresh impetus: the state of North Rhine-Westphalia is supporting a group of researchers at the Faculty of Medicine to introduce Kallikrein 8 as an early biomarker in the diagnosis and target molecule for the treatment of Alzheimer’s disease. The institute’s research project for neuropathology is one of eleven university projects that will be funded in the second tendering round of the North Rhine-Westphalian patent validation programme. The property rights of the project approach have been protected by a patent application.